Department Experimental Immunology, Academic Medical Centre, Amsterdam, The Netherlands.
Allergy. 2012 Nov;67(11):1383-91. doi: 10.1111/all.12017. Epub 2012 Sep 21.
The mechanism by which many monosensitized allergic individuals progress to polysensitization over time remains to be elucidated. Mouse models have contributed greatly to the understanding of sensitization to inhaled allergens in healthy airways but hardly any studies have addressed sensitization during established allergy. We hypothesized that an allergic inflammatory milieu might facilitate sensitization to inhaled allergens by the presence of mature dendritic cells (DCs) and IL-4.
Mice with house dust mite (HDM)-induced allergic airway inflammation received a single intratracheal dose of ovalbumin (OVA), 2 days after the last HDM exposure. Ten days later, sensitization was assessed by rechallenge with OVA. We evaluated the following factors for their importance in neosensitization: (1) maturation and recruitment of DCs to the airways, (2) dependency on DCs using CD11cDTR conditional knockout mice, (3) presence of ongoing airway inflammation by comparing sensitization at day 2 and day 14 after the last HDM exposure and (4) dependency on IL-4 by treatment with blocking antibodies.
House dust mite -induced inflammation facilitated neosensitization to OVA. HDM-induced inflammation increased the number of airway DCs with a mature phenotype but a DC reduction of 93% did not inhibit sensitization. Neosensitization to OVA was dependent on ongoing inflammation and in particular on IL-4.
These findings show that HDM-induced allergic airway inflammation facilitates neosensitization to a second inhaled allergen in an IL-4-dependent manner and provide insight into the underlying mechanism of the frequently observed progression to polysensitization in HDM-monosensitized individuals.
许多单致敏过敏个体随着时间的推移发展为多致敏的机制仍有待阐明。小鼠模型极大地促进了对健康气道中吸入性过敏原致敏的理解,但几乎没有研究涉及已确立的过敏期间的致敏。我们假设过敏性炎症环境可能通过成熟树突状细胞 (DC) 和 IL-4 的存在促进对吸入性过敏原的致敏。
接受屋尘螨 (HDM) 诱导的过敏性气道炎症的小鼠在最后一次 HDM 暴露后 2 天接受单次气管内卵清蛋白 (OVA) 剂量。10 天后,通过再次用 OVA 激发来评估致敏情况。我们评估了以下因素对新致敏的重要性:(1) DC 向气道的成熟和募集,(2) 使用 CD11cDTR 条件性敲除小鼠的依赖性,(3) 通过比较最后一次 HDM 暴露后第 2 天和第 14 天的气道炎症来评估持续存在的气道炎症,以及 (4) 通过使用阻断抗体来评估对 IL-4 的依赖性。
HDM 诱导的炎症促进了对 OVA 的新致敏。HDM 诱导的炎症增加了具有成熟表型的气道 DC 数量,但减少 93%的 DC 并不抑制致敏。OVA 的新致敏依赖于持续的炎症,特别是依赖于 IL-4。
这些发现表明,HDM 诱导的过敏性气道炎症以依赖 IL-4 的方式促进对第二种吸入性过敏原的新致敏,并深入了解 HDM-单致敏个体中经常观察到的多致敏进展的潜在机制。